Sponsor pipeline

Suzhou Suncadia Biopharmaceuticals Co., Ltd. clinical trial pipeline

Get alerts when Suzhou Suncadia Biopharmaceuticals Co., Ltd.'s trials change

73 active trials 51 recruiting 24 Phase 3 23 disease areas 13 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-09-12
critical
NCT06840002 A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent… · Phase 1/2
2026-09-09
notable
NCT06844474 A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC · Phase 2
2026-09-09
notable
NCT07735377 A Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability… · Phase 1
2026-09-26
notable
NCT06929624 A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse… · Phase 3
2026-09-26
notable
NCT07183189 A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line… · Phase 3
2026-09-10
notable
NCT07679360 A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's… · Phase 3
2026-09-09
notable
NCT07676162 A Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus… · Phase 3
2026-09-09
notable
NCT07726992 A Study of SHR-1501 Combination With BCG Versus Placebo Combined With BCG in Subjects… · Phase 3
2026-09-17
notable
NCT07751341 A Clinical Study of SHR-9839 as Monotherapy or in Combination With Chemotherapy Plus… · Phase 2
2026-09-29
notable
NCT07691762 A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in… · Phase 3
2026-09-26
notable
NCT06618664 A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab… · Phase 3

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-21 NCT07830199 A Clinical Study of SHR-4595 Injection in Patients With Advanced Solid Tumors to Evaluate… Phase 1 Not Yet Recruiting

Active trials by phase

Phase 1
18
Phase 1/2
14
Phase 2
16
Phase 2/3
2
Phase 3
22
Phase 4
1

Active trials top 25 of 73

NCT IDTitleConditionStatusUpdated
Phase 4
NCT06779097 Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis Moderate to Severe Plaque Psoriasis Not Yet Recruiting 2025-01-16
Phase 3
NCT06618664 A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab… Advanced Hepatocellular Carcinoma Recruiting 2026-09-25
NCT07676162 A Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus… Advanced Colorectal Cancer Recruiting 2026-09-10
NCT07679360 A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's… Triple Negative Breast Cancer Recruiting 2026-09-09
NCT07726992 A Study of SHR-1501 Combination With BCG Versus Placebo Combined With BCG in Subjects… Papillary-Only Non-muscle-invasive Bladder Cancer Recruiting 2026-09-08
NCT07393542 A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial… Locally Advanced or Metastatic Urothelial Carcinoma Recruiting 2026-08-14
NCT07424287 A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected… NMIBC Recruiting 2026-07-20
NCT07418749 A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With… Recurrent Cervical Cancer Recruiting 2026-04-06
NCT07118527 A Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in… Patients With Unresectable Locally Advanced or Metastatic Untreated Gastric or Gastroesophageal Junction Adenocarcinoma Recruiting 2026-02-11
NCT07229625 A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing… Advanced Biliary Tract Cancer Recruiting 2026-01-28
NCT07111832 A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer Recruiting 2025-12-18
NCT07170995 Phase III Study of SHR-8068 Combined With Adebrelimab and Chemotherapy Versus… Advanced or Metastatic Non-small Cell Lung Cancer Recruiting 2025-11-18
NCT06860750 A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial… Active Non-radiographic Axial Spondyloarthritis Recruiting 2025-06-22
NCT06394492 SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian… Ovarian Cancer Recruiting 2024-08-09
NCT07691762 A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in… Hepatocellular Carcinoma Not Yet Recruiting 2026-09-28
NCT06929624 A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse… Diffuse Large B-cell Lymphoma Active, Not Recruiting 2026-09-25
NCT07183189 A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line… Non-small Cell Lung Cancer Active, Not Recruiting 2026-09-25
NCT07779538 Clinical Trials Comparing Trastuzumab Plus Bevacizumab With Bevacizumab as First-line… Ovarian Cancer Not Yet Recruiting 2026-08-21
NCT06640257 A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis Psoriatic Arthritis Active, Not Recruiting 2026-08-06
NCT06671379 A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or… Non-small Cell Lung Cancer Active, Not Recruiting 2026-03-19
NCT06199973 Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced… Advanced Colorectal Cancer Active, Not Recruiting 2025-07-17
NCT04950322 A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal Cancer Gastric or Gastroesophageal Junction Cancer Active, Not Recruiting 2025-03-30
NCT06833307 The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to… Children and Adolescents Aged 6 to 18 With Moderate-to-Severe Plaque Psoriasis Not Yet Recruiting 2025-02-18
Phase 2/3
NCT06879145 Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With… Muscular Invasive Bladder Cancer (MIBC) Recruiting 2026-07-13
NCT07454720 A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as… Locally Advanced Resectable Rectal Cancer Recruiting 2026-05-05

Disease areas by active trials, top 10 of 23

Get alerts when Suzhou Suncadia Biopharmaceuticals Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free